Related Experiment Videos

Interferon-gamma and interleukin-12 pathway defects and human disease

S E Dorman1, S M Holland

  • 1Laboratory of Host Defenses, National Institutes of Health, NIAID, Building 10, Room 11N103, 10 Center Dr, MSC 1886, Bethesda, MD 20892, USA.

Insights

Genetic mutations in interferon-gamma (IFNgamma) receptor and IL-12 pathway genes increase susceptibility to mycobacterial diseases. Studying these genetic deficiencies enhances understanding of host defense against intracellular pathogens.

Area of Science:

  • Immunology
  • Genetics
  • Infectious Diseases

Background:

  • Human susceptibility to mycobacterial diseases has long been suspected to have a genetic basis.
  • Recent discoveries have identified specific gene mutations contributing to this susceptibility.

Purpose of the Study:

  • To describe genotype-phenotype correlations in deficiencies of the interferon-gamma (IFNgamma) receptor, IL-12 receptor beta1 (IL-12Rbeta1), and IL-12 p40 genes.
  • To discuss how studying these genetic diseases advances knowledge of human host defense against mycobacteria and other intracellular pathogens.

Main Methods:

  • Review of genotype-phenotype correlations in patients with genetic deficiencies.
  • Analysis of susceptibility to intracellular pathogens in relation to specific gene mutations.

Main Results:

  • Mutations in IFNgamma receptor, IL-12Rbeta1, and IL-12 p40 genes are linked to increased susceptibility to mycobacterial and other intracellular infections.
  • These deficiencies manifest in heightened vulnerability to diseases caused by nontuberculous mycobacteria, BCG, Salmonella, and certain viruses.

Conclusions:

  • Genetic factors play a crucial role in determining susceptibility to mycobacterial diseases.
  • Understanding these genetic deficiencies provides critical insights into the mechanisms of human host defense against a range of intracellular pathogens.

Related Concept Videos